Improved tumor-targeting MRI contrast agents: Gd(DOTA) conjugates of a cycloalkane-based RGD peptide. [electronic resource]
- Biochemical and biophysical research communications Dec 2014
- 246-50 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1090-2104
10.1016/j.bbrc.2014.10.155 doi
Animals Cell Line, Tumor Chromatography, High Pressure Liquid Contrast Media--chemistry Cycloparaffins--chemistry Female Gadolinium--chemistry Heterocyclic Compounds--chemistry Humans Integrins--chemistry Kidney--metabolism Magnetic Resonance Imaging--methods Mice Mice, Inbred BALB C Neoplasm Transplantation Oligopeptides--chemistry Organometallic Compounds--chemistry Protein Binding Urinary Bladder--metabolism